Griffiths William, Davies Susan, Gibbs Paul, Thillainayagam Andrew, Alexander Graeme
Department of Hepatology, Addenbrooke's Hospital, Box 210, Cambridge CB2 2QQ, UK.
J Hepatol. 2006 Apr;44(4):829-31. doi: 10.1016/j.jhep.2005.12.024. Epub 2006 Feb 3.
Sclerosing cholangitis due to Langerhans cell histiocytosis (LCH) is a rare cause of end-stage liver disease, seen mainly in children. Only a few adult cases have been reported worldwide. Liver transplantation may be a viable treatment option for what is otherwise an irreversible condition. We describe a 65-year-old female with LCH who developed severe sclerosing cholangitis with jaundice, intractable pruritus and peritoneal disease. She underwent orthotopic liver transplantation with complete amelioration of symptoms and remained well 14 months following her operation. Explant histology confirmed LCH involvement with an associated extensive sclerosing cholangitis. Symptomatic LCH cholangiopathy is an emerging indication for liver transplantation in adults.
朗格汉斯细胞组织细胞增多症(LCH)所致硬化性胆管炎是终末期肝病的罕见病因,主要见于儿童。全球仅报道了少数成年病例。对于这种原本不可逆的疾病,肝移植可能是一种可行的治疗选择。我们描述了一名65岁的LCH女性患者,她出现了伴有黄疸、顽固性瘙痒和腹膜疾病的严重硬化性胆管炎。她接受了原位肝移植,症状完全缓解,术后14个月情况良好。切除组织学检查证实LCH累及并伴有广泛的硬化性胆管炎。有症状的LCH胆管病是成人肝移植的一个新适应症。